These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7905970)

  • 1. High-purity factor concentrates in prevention of AIDS.
    Schwarz HP; Kunschak M; Engl W; Eibl J
    Lancet; 1994 Feb; 343(8895):478-9. PubMed ID: 7905970
    [No Abstract]   [Full Text] [Related]  

  • 2. FVIII concentrates: old and new.
    Andes WA
    Thromb Res; 1990 Feb; 57(4):673. PubMed ID: 2109372
    [No Abstract]   [Full Text] [Related]  

  • 3. High purity factor VIII and immune state in HIV.
    Nurs Stand; 1993 Oct 6-12; 8(3):17. PubMed ID: 8217692
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: non-HIV hypotheses must be studied more carefully.
    Duesberg P
    BMJ; 1996 Jan; 312(7025):210-1. PubMed ID: 8563583
    [No Abstract]   [Full Text] [Related]  

  • 5. Surveillance and care of four Chinese hemophiliacs with human immunodeficiency virus (HIV) infection.
    Tang D; Qu G; Pang X; Lang Y; Liang Y; Yu Y; Zeng Y; Shao Y
    Chin Med Sci J; 1993 Mar; 8(1):41-3. PubMed ID: 8274721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophilia and the human immunodeficiency virus.
    Slater PE
    Isr J Med Sci; 1991 Oct; 27(10):572-4. PubMed ID: 1955312
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor VIII concentrates in HIV-1-positive hemophiliacs--is pure better?
    Eichinger S; Pabinger I; Kyrle PA; Köller U; Kier P; Schneider B; Lechner K
    Haemostasis; 1992; 22(1):25-31. PubMed ID: 1521824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status.
    Seremetis SV; Aledort LM; Bergman GE; Bona R; Bray G; Brettler D; Eyster ME; Kessler C; Lau TS; Lusher J
    Lancet; 1993 Sep; 342(8873):700-3. PubMed ID: 8103820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort Study.
    Goedert JJ; Cohen AR; Kessler CM; Eichinger S; Seremetis SV; Rabkin CS; Yellin FJ; Rosenberg PS; Aledort LM
    Lancet; 1994 Sep; 344(8925):791-2. PubMed ID: 7916077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purity of factor VIII concentrates and immune function in hemophiliacs.
    Farrugia A
    Blood; 1992 May; 79(10):2800-1. PubMed ID: 1586729
    [No Abstract]   [Full Text] [Related]  

  • 11. Proposed protocol for the evaluation of the effect of high purity factor concentrates on the immune system of hemophilia patients.
    Brettler DB
    Thromb Haemost; 1989 Sep; 62(2):811-2. PubMed ID: 2510353
    [No Abstract]   [Full Text] [Related]  

  • 12. Clotting factor concentrated--whither purity?
    Thomas DP
    Thromb Haemost; 1995 Dec; 74(6):1604-6. PubMed ID: 8772244
    [No Abstract]   [Full Text] [Related]  

  • 13. Very-high-purity versus intermediate-purity factor VIII in human immunodeficiency virus-positive hemophiliacs: conclusions of a prospective 3-year study. Monoclate Study Group.
    Seremetis SV
    Semin Hematol; 1993 Oct; 30(4 Suppl 5):10-3. PubMed ID: 7903480
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenesis of AIDS in hemophilia.
    Ablin RJ
    Ann Allergy; 1990 Mar; 64(3):322. PubMed ID: 2106808
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of recombinant factor VIII in the management of hemophilia.
    Mannucci PM; Gringeri A
    Ric Clin Lab; 1991; 21(1):1-7. PubMed ID: 1907760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 cells in HIV-1 infected hemophiliacs: effect of factor VIII concentrates.
    Goldsmith JM; Deutsche J; Tang M; Green D
    Thromb Haemost; 1991 Oct; 66(4):415-9. PubMed ID: 1839091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate.
    de Biasi R; Rocino A; Miraglia E; Mastrullo L; Quirino AA
    Blood; 1991 Oct; 78(8):1919-22. PubMed ID: 1822966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purity of factor VIII concentrates and serial CD4 counts. The Transfusion Safety Study Group.
    Hilgartner MW; Buckley JD; Operskalski EA; Pike MC; Mosley JW
    Lancet; 1993 May; 341(8857):1373-4. PubMed ID: 8098792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Consensus hemophilia treatment].
    Briët E; Breederveld C
    Ned Tijdschr Geneeskd; 1987 Oct; 131(43):1914-6. PubMed ID: 3120016
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of recombinant antihemophilic factor in the treatment of two patients with classic hemophilia.
    White GC; McMillan CW; Kingdon HS; Shoemaker CB
    N Engl J Med; 1989 Jan; 320(3):166-70. PubMed ID: 2492083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.